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Epithelial differentiation requires a balancing act to commit to epithelial fate while inhibiting both progenitor
and mesenchymal traits. In this issue of Developmental Cell, Lee et al. (2014) and Watanabe et al. (2014)
uncover a critical role of Ovol proteins in safeguarding this intricate process.Epithelial cells hold remarkable plasticity:
they are able to self-renew, expand, and
differentiate during embryonic develop-
ment, tissue maintenance, and disease
pathogenesis. It is also well documented
that epithelial cells can lose defining
epithelial features and transition into a
mesenchymal state by activating the
epithelial-mesenchymal transition (EMT)
program. Although the upstream inducing
signals vary in different tissues, execution
of the EMT program is orchestrated by a
group of EMT core transcription factors,
including the Snail, Twist, and Zeb family
proteins (Yang and Weinberg, 2008).
This program is essential for many embry-
onic developmental events during which
epithelial cells give rise to migratory
mesenchymal descendants. Surprisingly,
two studies in the current issue of Devel-
opmental Cell reveal that the simmering
EMT program in epithelial tissues needs
to be actively repressed to ensure normal
epithelial differentiation (Lee et al., 2014;
Watanabe et al., 2014).
These two studies examined epithelial
differentiation in two of the most well-
characterized epithelia, the epidermis
and the female mammary gland. Develop-
mentally, the multilayered epidermis is
derived from a single-layered surface
ectoderm with intact epithelial junctions
and classical polarized epithelial mor-
phology. During epidermal differentiation,
the basal cells delaminate, migrate, and
differentiate while maintaining their pro-
genitor cell pool. The crucial epithelial
junction protein, E-cadherin, and its cyto-
plasmic partner b-catenin are indispens-
able during this process. Additionally,
EMT regulators such as Snail1 (Jamora
et al., 2005), Snail2 (Shirley et al., 2010),
and Twist2 (Sosic et al., 2003) are presentat the epidermis, and disruption of their
expression individually results in abnor-
malities in epidermis development. The
mammary gland, which consists of
epithelial luminal cells lined with myo-
epithelial cells in the structure of a
ductal tree, first forms prenatally, then un-
dergoes branching expansion during pu-
berty and pregnancy. The growth of the
mammary ductal tree during puberty is
achieved by secondary branching from
the primary ducts and bifurcation of the
terminal end buds (TEBs), small acinar-
like structures at the tip of the mammary
ducts. The differentiating TEBs elongate
the mammary ducts, invade the mam-
mary fat pad, and continue to proliferate
to form alveolar structures during preg-
nancy. Similar to the epidermis, the EMT
regulator Snail2 (Guo et al., 2012) was
also found to play an important role in
regulating mammary stem cell states.
Lee et al. (2014) and Watanabe et al.
(2014) reveal the critical role of two Ovol
family transcription factors, Ovol1 and
Ovol2, in safeguarding the lineage speci-
ficity of epithelial cells against the mesen-
chymal state in the embryonic epidermis
and the mammary gland. Ovol1 and
Ovol2 are zinc-finger transcription factors
that function downstream of key develop-
mental pathways such as Wnt, EGF, and
BMP. Although deletion of Ovol proteins
in mice results in various epithelial anom-
alies (Dai et al., 1998), their cellular func-
tions in epithelial development are largely
unknown.
Lee et al. (2014) found that in the em-
bryonic epidermis, depletion of Ovol1
and Ovol2 triggered expansion of the
epidermal basal compartment, where
the skin progenitor cells reside. Mean-
while, Watanabe et al. (2014) showedDevelopmental Ccompelling data that, upon deletion of
Ovol2 in the mammary gland, branching
morphogenesis during puberty was im-
paired, as demonstrated by severe under-
development of the mammary ductal
trees. Mechanistically, both studies
showed that deletion of Ovol proteins
led to EMT in the epithelial tissues, char-
acterized by an increased number of
vimentin-positive cells and overall enrich-
ment of EMT-related gene signatures.
Using immortalized mouse mammary
cells, Watanabe et al. (2014) showed
that Ovol2 functions as a master suppres-
sor of almost all known EMT-inducing
transcription factors by directly binding
to their promoters. Zeb1 was revealed to
be a key downstream target of Ovol in
both epithelial systems, because Zeb1
depletion alone was able to rescue the
differentiation defects stemming from
depletion of Ovol proteins in both the
epidermis and the mammary duct. These
studies highlight the importance of Ovol
proteins in suppressing mesenchymal
traits during epithelial differentiation and
add new players to the already-complex
epithelial differentiation program.
In addition to Ovol proteins, a previous
study showed that the transcription factor
Elf5 appears to suppress EMT during
mammary gland alveologenesis by sup-
pressing Snail2 transcription (Chakrabarti
et al., 2012a). Deletion of Elf5 leads to
enrichment of vimentin-positive cells and
K8/K14 double-positive progenitor cells
in the breast (Chakrabarti et al., 2012a,
2012b). Together with the two studies
in this issue of Developmental Cell,
these observations suggest an interesting
model for epithelial differentiation in
which the differentiating epithelial cells
require an active gatekeeper, such asell 29, April 14, 2014 ª2014 Elsevier Inc. 1
Figure 1. Ovol Proteins Guard Epithelial Differentiation by
Suppressing EMT
During normal development of themammary gland and epidermis inmice (left),
Ovol transcription factors suppress the expression of Zeb1 and the EMT
program to safeguard epithelial identity during differentiation. Deletion of
the Ovol proteins (right) causes excessive activation of the EMT program
mainly through the upregulation of Zeb1 expression. Increased numbers of
vimentin-positive cells (labeled in red) were evident in both the mammary
TEB and epidermal basal cells. This misactivated EMT program interferes
with proper epithelial differentiation and results in defects in mammary duct
elongation and expansion of the epidermal basal compartment.
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Previewsthe Ovol proteins, to prevent
mesenchymal transdifferen-
tiation and maintain their
epithelial identity (Figure 1).
This model raises the ques-
tion of why committed epi-
thelial cell lineage retains the
capacity to undergo EMT.
One plausible clue is that in
both the epidermis andmam-
mary TEBs, migration of the
epithelial progenitor cells is
critical for their proper differ-
entiation. Is it possible that
the EMT program is tran-
siently and/or partially turned
on to fulfill such a migratory
need of the progenitor cells?
If so, how do these mesen-
chymal-like cells relate to the
epithelial progenitor cells?
These questions may be
addressed through cellular
and molecular characteriza-
tion of such cells in vivo. In
the mammary gland, deletion
of Ovol2 results in EMT in
TEBs during puberty. In con-
trast, deletion of Elf5 onlyleads to EMT in alveoli during pregnancy.
Does this suggest that different EMT
suppressors operate at different stages
of mammary epithelial differentiation?
And, if so, is there cooperation between
these processes? Further studies are
needed to clarify these newly raised
questions.
Finally, it bears noting that the EMT
program is critical for breast cancer
metastasis. In light of this, Watanabe2 Developmental Cell 29, April 14, 2014 ª201et al. (2014) touched upon the possible
involvement of Ovol2 in breast cancer
progression and showed that low
Ovol2 expression is significantly cor-
related with poor survival in patients.
Given the dynamic involvement of the
EMT/MET program at different steps of
metastasis (Tsai and Yang, 2013), further
examination of Ovol proteins in mouse
tumor models and patient samples will
be needed to fully understand their bio-4 Elsevier Inc.logical significance in meta-
static breast cancer.REFERENCES
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